Professor Ian Yang
Professor

Ian Yang

Email: 
Phone: 
+61 7 3139 5050

Background

Professor Ian Yang is a Thoracic Physician and Director of Thoracic Medicine at The Prince Charles Hospital, and Head of the PCH-Northside Clinical Unit, School of Clinical Medicine, Faculty of Medicine, The University of Queensland, Brisbane, Australia.

Availability

Professor Ian Yang is:
Available for supervision

Fields of research

Biomedical and Clinical Sciences Cardiovascular medicine and haematology Clinical sciences Oncology and carcinogenesis Respiratory diseases

Qualifications

  • Bachelor (Honours) of Medicine Surgery, The University of Queensland
  • Postgraduate Diploma, University of Newcastle
  • Doctor of Philosophy, The University of Queensland
  • Asian Pacific Society of Respirology, Asian Pacific Society of Respirology
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians
  • The Thoracic Society of Australia and New Zealand, The Thoracic Society of Australia and New Zealand

Research interests

  • Clinical and translational research in chronic lung diseases

    Pathogenesis, diagnosis and treatment of chronic lung diseases, including COPD, asthma, lung cancer, mesothelioma and effects of air pollution

Research impacts

His clinical work is in the field of thoracic medicine, and his research team is studying gene-environmental interaction in COPD, asthma, lung cancer and air pollution. He is involved in the training of higher degree students in translational research into lung diseases.

He is a Chair of the National COPD Guidelines Committee of the Lung Foundation Australia, and a member of the COPD Coordinating Committee. He is Chair of the Medical Programs and Research Advisory Committee of the Asthma Foundation Queensland NSW.

Search Professor Ian Yang’s works on UQ eSpace

360 works between 1999 and 2025
All (360) Journal Article (265) Book Chapter (10) Conference Publication (84) Other Outputs (1)

161 - 180 of 360 works

2017

Journal Article

Is Digital Tomosynthesis on Par With Computed Tomography for the Detection and Measurement of Pulmonary Nodules?

Lee, Xiang Wen, Marshall, Henry M., Leong, Steven C., O'Rourke, Rachael L., Steinke, Karin, Mirjalili, Negar, Bowman, Rayleen V., Yang, Ian A. and Fong, Kwun M. (2017). Is Digital Tomosynthesis on Par With Computed Tomography for the Detection and Measurement of Pulmonary Nodules?. Journal of Thoracic Imaging, 32 (6), W67-W68. doi: 10.1097/RTI.0000000000000298

Is Digital Tomosynthesis on Par With Computed Tomography for the Detection and Measurement of Pulmonary Nodules?

2017

Journal Article

RE: Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions

Page, Barbara J, Bowman, Rayleen V, Yang, Ian A and Fong, Kwun M (2017). RE: Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions. Journal of the National Cancer Institute, 110 (4), 432-432. doi: 10.1093/jnci/djx216

RE: Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions

2017

Journal Article

Ist eine thrombophilie-untersuchung bei patienten mit venöser thromboembolie notwendig?

Kudo, M., Lee, H. L., Yang, I. A. and Masel, P. J. (2017). Ist eine thrombophilie-untersuchung bei patienten mit venöser thromboembolie notwendig?. Vasomed, 29 (5).

Ist eine thrombophilie-untersuchung bei patienten mit venöser thromboembolie notwendig?

2017

Journal Article

Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial

Gibson, Peter G., Yang, Ian A., Upham, John W., Reynolds, Paul N., Hodge, Sandra, James, Alan L., Jenkins, Christine, Peters, Matthew J., Marks, Guy B., Baraket, Melissa, Powell, Heather, Taylor, Steven L., Leong, Lex E. X., Rogers, Geraint B. and Simpson, Jodie L. (2017). Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. The Lancet, 390 (10095), 659-668. doi: 10.1016/S0140-6736(17)31281-3

Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial

2017

Journal Article

Oxidative potential of gas phase combustion emissions - an underestimated and potentially harmful component of air pollution from combustion processes

Stevanovic, S., Vaughan, A., Hedayat, F., Salimi, F., Rahman, M. M., Zare, A., Brown, R. A., Brown, R. J., Wang, H., Zhang, Z., Wang, X., Bottle, S. E., Yang, I. A. and Ristovski, Z. D. (2017). Oxidative potential of gas phase combustion emissions - an underestimated and potentially harmful component of air pollution from combustion processes. Atmospheric Environment, 158, 227-235. doi: 10.1016/j.atmosenv.2017.03.041

Oxidative potential of gas phase combustion emissions - an underestimated and potentially harmful component of air pollution from combustion processes

2017

Journal Article

Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology

Taylor, Steven L., Leong, Lex E. X., Choo, Jocelyn M., Wesselingh, Steve, Yang, Ian A., Upham, John W., Reynolds, Paul N., Hodge, Sandra, James, Alan L., Jenkins, Christine, Peters, Matthew J., Baraket, Melissa, Marks, Guy B., Gibson, Peter G., Simpson, Jodie L. and Rogers, Geraint B. (2017). Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology. Journal of Allergy and Clinical Immunology, 141 (1), 94-103.e15. doi: 10.1016/j.jaci.2017.03.044

Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology

2017

Journal Article

Radiation therapy for preventing instrumentation track metastases in malignant pleural mesothelioma

Eastment, J. G., Burke, J. P., Fong, K. M., Yang, I. A. and Bowman, R. V. (2017). Radiation therapy for preventing instrumentation track metastases in malignant pleural mesothelioma. Cochrane Database of Systematic Reviews, 2017 (2) CD012541. doi: 10.1002/14651858.CD012541

Radiation therapy for preventing instrumentation track metastases in malignant pleural mesothelioma

2017

Journal Article

Genomics of lung cancer

Fong, Kwun M., Bowman, Rayleen V. and Yang, Ian A. (2017). Genomics of lung cancer. Journal of Thoracic Disease, 9 (2), E155-E157. doi: 10.21037/jtd.2017.02.29

Genomics of lung cancer

2017

Book Chapter

Molecular basis of lung carcinogenesis

Fong, Kwum M., Larsen, Jill E., Wright, Casey M., Sriram, Krishna, Davidson, Morgan, Daniels, Marissa, Sekido, Yoshitaka, Bowman, Rayleen V., Yang, Ian A. and Minna, John D. (2017). Molecular basis of lung carcinogenesis. The molecular basis of human cancer. (pp. 447-496) edited by William B. Coleman and Gregory J. Tsongalis. Totowa, NJ, United States: Humana Press. doi: 10.1007/978-1-59745-458-2_28

Molecular basis of lung carcinogenesis

2017

Conference Publication

Effects of N-acetylcysteine intervention in vitro on primary human bronchial epithelial cells exposed to diesel emissions

Vaughan, Annalicia, Stevanovic, Svetlana, Jafari, Mohammad, Miljevic, Branka, Ristovski, Zoran, Bowman, Rayleen, Fong, Kwun and Yang, Ian (2017). Effects of N-acetylcysteine intervention in vitro on primary human bronchial epithelial cells exposed to diesel emissions. ANZSRS/TSANZ, Canberra, ACT, Australia, 24-28 March 2017. Richmond, VIC, Australia: Wiley-Blackwell.

Effects of N-acetylcysteine intervention in vitro on primary human bronchial epithelial cells exposed to diesel emissions

2016

Journal Article

Utility of thrombophilia testing in patients with venous thromboembolism

Kudo, Masataka, Lee, Huang L., Yang, Ian A. and Masel, Philip J. (2016). Utility of thrombophilia testing in patients with venous thromboembolism. Journal of Thoracic Disease, 8 (12), 3697-3703. doi: 10.21037/jtd.2016.12.40

Utility of thrombophilia testing in patients with venous thromboembolism

2016

Journal Article

Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria

Hew, M., Gillman, A., Sutherland, M., Wark, P., Bowden, J., Guo, M., Reddel, H. K., Jenkins, C., Marks, G. B., Thien, F., Rimmer, J., Katsoulotos, G. P., Cook, M., Yang, I., Katelaris, C., Bowler, S., Langton, D., Wright, C., Bint, M., Yozghatlian, V., Burgess, S., Sivakumaran, P., Yan, K. Y., Kritikos, V., Peters, M., Baraket, M., Aminazad, A., Robinson, P., Jaffe, A. ... Gibson, P. G. (2016). Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria. Clinical and Experimental Allergy, 46 (11), 1407-1415. doi: 10.1111/cea.12774

Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria

2016

Journal Article

Acute exacerbation of COPD

Ko, Fanny W., Chan, Ka Pang, Hui, David S., Goddard, John R., Shaw, Janet G., Reid, David W. and Yang, Ian A. (2016). Acute exacerbation of COPD. Respirology, 21 (7), 1152-1165. doi: 10.1111/resp.12780

Acute exacerbation of COPD

2016

Journal Article

Brief tailored smoking cessation counseling in a lung cancer screening population is feasible: a pilot randomized controlled trial

Marshall, Henry M., Courtney, Deborah A., Passmore, Linda H., McCaul, Elizabeth M., Yang, Ian A., Bowman, Rayleen V. and Fong, Kwun M. (2016). Brief tailored smoking cessation counseling in a lung cancer screening population is feasible: a pilot randomized controlled trial. Nicotine and Tobacco Research, 18 (7), 1665-1669. doi: 10.1093/ntr/ntw010

Brief tailored smoking cessation counseling in a lung cancer screening population is feasible: a pilot randomized controlled trial

2016

Journal Article

Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry

Gibson, P. G., Reddel, H., McDonald, V. M., Marks, G., Jenkins, C., Gillman, A., Upham, J., Sutherland, M., Rimmer, J., Thien, F., Katsoulotos, G. P., Cook, M., Yang, I., Katelaris, C., Bowler, S., Langton, D., Robinson, P., Wright, C., Yozghatlian, V., Burgess, S., Sivakumaran, P., Jaffe, A., Bowden, J., Wark, P. A., Yan, K. Y., Kritikos, V., Peters, M., Hew, M., Aminazad, A. ... Guo, M. (2016). Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry. Internal Medicine Journal, 46 (9), 1054-1062. doi: 10.1111/imj.13166

Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry

2016

Journal Article

Periostin levels and eosinophilic inflammation in poorly-controlled asthma

Simpson, Jodie L., Yang, Ian A., Upham, John W., Reynolds, Paul N., Hodge, Sandra, James, Alan L., Jenkins, Christine, Peters, Matthew J., Jia, Guiquan, Holweg, Cecile T. J. and Gibson, Peter G. (2016). Periostin levels and eosinophilic inflammation in poorly-controlled asthma. BMC Pulmonary Medicine, 16 (1) 67, 67.1-67.7. doi: 10.1186/s12890-016-0230-4

Periostin levels and eosinophilic inflammation in poorly-controlled asthma

2016

Conference Publication

EFFECTIVENESS AND RESPONSE PREDICTORS OF OMALIZUMAB IN A SEVERE ALLERGIC ASTHMA POPULATION WITH A HIGH PREVALENCE OF COMORBIDITIES: THE AUSTRALIAN XOLAIR REGISTRY

Gibson, P., Reddel, H., Jenkins, C., Marks, G., Upham, J., Gillman, A., Thien, F., Sutherland, M., Rimmer, J., Katsoulotos, G., Cook, M., Yang, , Katelaris, C., Bowler, S., Langton, D., Robinson, P., Wright, C., Yozghatlian, , Burgess, S., Mcdonald, , Sivakumaran, P., Jaffe, A., Bowden, J., Guo, M., Wark, P., Yan, K. Y., Kritikos, V., Peters, M., Baraket, M. ... Bint, M. (2016). EFFECTIVENESS AND RESPONSE PREDICTORS OF OMALIZUMAB IN A SEVERE ALLERGIC ASTHMA POPULATION WITH A HIGH PREVALENCE OF COMORBIDITIES: THE AUSTRALIAN XOLAIR REGISTRY. HOBOKEN: WILEY-BLACKWELL.

EFFECTIVENESS AND RESPONSE PREDICTORS OF OMALIZUMAB IN A SEVERE ALLERGIC ASTHMA POPULATION WITH A HIGH PREVALENCE OF COMORBIDITIES: THE AUSTRALIAN XOLAIR REGISTRY

2016

Journal Article

Screen-detected subsolid pulmonary nodules: long-term follow-up and application of the PanCan lung cancer risk prediction model

Zhao, Henry, Marshall, Henry M., Yang, Ian A., Bowman, Rayleen V., Ayres, John, Crossin, Jane, Lau, Melanie, Slaughter, Richard E., Redmond, Stanley, Passmore, Linda, McCaul, Elizabeth, Courtney, Deborah, Leong, Steven C., Windsor, Morgan, Zimmerman, Paul V. and Fong, Kwun M. (2016). Screen-detected subsolid pulmonary nodules: long-term follow-up and application of the PanCan lung cancer risk prediction model. British Journal of Radiology, 89 (1060) 20160016, 20160016. doi: 10.1259/bjr.20160016

Screen-detected subsolid pulmonary nodules: long-term follow-up and application of the PanCan lung cancer risk prediction model

2016

Journal Article

Use of inhaled corticosteroids in COPD: improving efficacy

Yang, Ian A., Shaw, Janet G., Goddard, John R., Clarke, Melissa S. and Reid, David W. (2016). Use of inhaled corticosteroids in COPD: improving efficacy. Expert Review of Respiratory Medicine, 10 (3), 339-350. doi: 10.1586/17476348.2016.1151789

Use of inhaled corticosteroids in COPD: improving efficacy

2016

Journal Article

Reduced antiviral interferon production in poorly controlled asthma is associated with neutrophilic inflammation and high-dose inhaled corticosteroids

Simpson, Jodie L., Carroll, Melanie, Yang, Ian A., Reynolds, Paul N., Hodge, Sandra, James, Alan L., Gibson, Peter G. and Upham, John W. (2016). Reduced antiviral interferon production in poorly controlled asthma is associated with neutrophilic inflammation and high-dose inhaled corticosteroids. Chest, 149 (3), 704-713. doi: 10.1016/j.chest.2015.12.018

Reduced antiviral interferon production in poorly controlled asthma is associated with neutrophilic inflammation and high-dose inhaled corticosteroids

Current funding

  • 2025 - 2027
    Extracellular-vesicles derived RNA biomarkers of lung cancer in never-smokers for early cancer detection
    Prince Charles Hospital Foundation
    Open grant
  • 2024 - 2026
    Changes in the lung microbiome with use of inhaled steroids in chronic obstructive pulmonary disease (COPD)
    Prince Charles Hospital Foundation
    Open grant
  • 2024 - 2025
    Lung Cancer Screening in Queensland
    Cancer Council Queensland
    Open grant
  • 2023 - 2026
    'Max Up' Trial - Maximising uptake of lung cancer screening and smoking cessation outcomes
    NHMRC MRFF EMCR - Early to Mid-Career Researchers
    Open grant
  • 2023 - 2025
    Transforming the care of people living with chronic obstructive pulmonary disease (COPD) using digital health
    Prince Charles Hospital Foundation
    Open grant
  • 2022 - 2026
    Defining the role and therapeutic manipulation of the gut-lung axis in respiratory disease (NHMRC Synergy administered by University of Technology Sydney)
    University of Technology Sydney
    Open grant
  • 2021 - 2025
    ACRF Lung Cancer Screening CENTRE OF EXCELLENCE (LUSCE)
    Australian Cancer Research Foundation
    Open grant
  • 2021 - 2026
    Lung cancer screening for early detection
    NHMRC MRFF EPCDR - Improving Diagnosis in Cancers with Low Survival Rates
    Open grant
  • 2021 - 2025
    Activating primary care COPD patients with Multi-morbidity (APCOM) study (MRFF Primary Health Care Research Grant led by Bond University)
    Bond University
    Open grant

Past funding

  • 2024 - 2025
    Cassette printer replacement (TPCHF Equipment Grant)
    Prince Charles Hospital Foundation
    Open grant
  • 2021 - 2023
    Inflammatory changes in 'onion skin' tissue layers surrounding the tumour site in lung cancer
    Prince Charles Hospital Foundation
    Open grant
  • 2020 - 2021
    TapeStation 4150
    Prince Charles Hospital Foundation
    Open grant
  • 2019 - 2020
    Inflammatory and DNA damage mechanisms in response to e-cigarette aerosols in COPD/lung cancer primary human bronchial epithelial cells
    Prince Charles Hospital Foundation
    Open grant
  • 2018 - 2020
    Extracellular vesicles as a novel biomarker for chronic obstructive pulmonary disease (COPD)
    Prince Charles Hospital Foundation
    Open grant
  • 2018 - 2024
    Dietary fibre and short chain fatty acids as immune regulators in COPD: a potential novel therapy
    Prince Charles Hospital Foundation
    Open grant
  • 2018 - 2019
    Bringing Modern Genomics to the Management of Lung Cancer in Queensland ( QGHA grant administered by QUT)
    Queensland University of Technology
    Open grant
  • 2017 - 2019
    Clinical trial validation of a blood exosome-prognosticator in lung cancer
    Prince Charles Hospital Foundation
    Open grant
  • 2017 - 2019
    Detection of microbial pathogens using quantitative polymerase chain reaction (qPCR) in patients with acute exacerbations of COPD
    Prince Charles Hospital Foundation
    Open grant
  • 2017 - 2021
    Testing the lung microbiome to predict risk of frequent exacerbations in COPD
    NHMRC Project Grant
    Open grant
  • 2016 - 2023
    ACRF Centre for Lung Cancer Early Detection
    Australian Cancer Research Foundation
    Open grant
  • 2016 - 2019
    Mobile health for COPD
    Prince Charles Hospital Foundation
    Open grant
  • 2016
    Using the lung microbiome to predict response to continuous antibiotics in COPD
    Australian Respiratory Council
    Open grant
  • 2015 - 2017
    SoM Leaders Research Support for Head Northside Clinical School
    Mayne Bequest Fund
    Open grant
  • 2014 - 2017
    The lung microbiome in coexisting COPD and bronchiectasis
    Prince Charles Hospital Foundation
    Open grant
  • 2014 - 2015
    Electronic Snapshot for Outpatient Management of COPD (ESO-COPD)
    Australian Centre for Health Services Innovation
    Open grant
  • 2013 - 2014
    Improving outcomes for patients with lung cancer and malignant mesothelioma
    Cancer Bequest Fund
    Open grant
  • 2013 - 2017
    PhD Scholarship in lung cancer - Funded by the Lung Foundation Australia/Neville Bantoft Bequest, with the UQ Thoracic Research Centre
    PhD Scholarship in Lung Cancer funded by the Lung Foundation Australia/Neville Bantoft Bequest
    Open grant
  • 2012 - 2017
    Clinical Academic Fellowship - Thoracic Physician
    Clinical Academic Fellowships
    Open grant
  • 2012 - 2017
    NHMRC Career Development Fellowship (Level 2): Preventing complications of chronic obstructive pulmonary disease
    NHMRC Career Development Award
    Open grant
  • 2012 - 2013
    Cigarette smoke and age-related epigenetic changes in the lung
    Prince Charles Hospital Foundation
    Open grant
  • 2012 - 2014
    Fundamental study into the role of the organic fraction on the toxicity of combustion generated airborne particles (ARC Discovery Project led by QUT)
    Queensland University of Technology
    Open grant
  • 2011 - 2012
    The Clinical Utility of High Resolution Melt Analysis in Detecting EGFR Mutations in the Serum of NSCLC Patients
    Pfizer Australia Pty Limited
    Open grant
  • 2011
    Tissue Culture Facility for the UQ Thoracic Research Centre
    NHMRC Equipment Grant
    Open grant
  • 2010 - 2011
    Novel microRNAs in pulmonary neoplasia
    Queensland Health
    Open grant
  • 2009 - 2012
    Mayne Bequest Fund Research Support Award: Thoracic Research
    Mayne Bequest Fund
    Open grant
  • 2009 - 2017
    Low dose CT screening for lung cancer
    Queensland Health Smart Health Research Grant
    Open grant
  • 2009 - 2012
    Genome-wide association study of protective alleles in lung cancer and chronic obstructive pulmonary disease
    Cancer Council Queensland
    Open grant
  • 2009 - 2015
    The AMAZES Study: Asthma and Macrolides: the AZithromycin Efficacy and Safety study (NHMRC Project Grant administered by University of Newcastle)
    University of Newcastle
    Open grant
  • 2008 - 2012
    Genomics of environmental stress and lung damage
    Queensland Health Smart Health Research Grant
    Open grant
  • 2007 - 2012
    Respiratory rehabilitation or self management for Chronic Obstructive Pulmonary Disease: what is the best management approach?
    Medical Benefits Fund of Australia Limited
    Open grant
  • 2007 - 2013
    Aberrant promoter methylation in lung cancer and smokers (TPCH)
    Queensland Health Smart Health Research Grant
    Open grant
  • 2007 - 2011
    Preventing progression of COPD
    NHMRC Career Development Award
    Open grant
  • 2006
    Innate Immunity genes in COPD
    Prince Charles Hospital Foundation
    Open grant
  • 2006
    Molecular pathways associated with the severity of COPD
    Prince Charles Hospital Foundation
    Open grant
  • 2006
    Slowing the Progression of Chronic Lung Disease
    Viertel Foundation (Sylvia and Charles Viertel)
    Open grant
  • 2006 - 2009
    The role of innate immunity genes in COPD
    NHMRC Project Grant
    Open grant
  • 2005 - 2006
    Innate immunity genes in asthma and allergy
    Asthma Foundation of Queensland
    Open grant

Availability

Professor Ian Yang is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Diagnosis and treatment of chronic obstructive pulmonary disease

    Improving approaches to the early diagnosis, monitoring and management of patients with COPD

  • Lung ageing

    Genetics and epigenetics of ageing in the lung

  • The lung's response to air pollution

    Gene-environment interaction in the lung's response to exposure to air pollutants

Supervision history

Current supervision

  • Master Philosophy

    Elastin turnover in the lung microenvironment and its significance in Lung Repair and Non-Small Cell Lung Carcinoma (NSCLC)

    Principal Advisor

    Other advisors: Professor Kwun Fong

  • Master Philosophy

    Elastin turnover in the lung microenvironment and its significance in Lung Repair and Non-Small Cell Lung Carcinoma (NSCLC)

    Principal Advisor

  • Doctor Philosophy

    Biomarkers of lung cancer

    Principal Advisor

    Other advisors: Professor Kwun Fong

  • Doctor Philosophy

    Precision medicine in the genomic era: emerging technologies for molecular profiling of lung cancer

    Associate Advisor

    Other advisors: Professor Kwun Fong

  • Doctor Philosophy

    Blood biomarkers for lung cancer screening

    Associate Advisor

    Other advisors: Professor Kwun Fong, Associate Professor Henry Marshall

  • Master Philosophy

    A multivariable prediction model for osteoporotic fracture in a lung cancer screening cohort

    Associate Advisor

    Other advisors: Professor Kwun Fong, Associate Professor Henry Marshall

  • Doctor Philosophy

    Molecular drivers of lung cancer.

    Associate Advisor

  • Doctor Philosophy

    Randomised pragmatic trial of comprehensive tissue sampling enabled by ultrathin bronchoscopic Radial probe EndoBronchial Ultrasound versus CT-guided TransThoracic needle aspiration/biopsy (REBUTT) for evaluation of peripheral pulmonary lesions.

    Associate Advisor

    Other advisors: Professor Kwun Fong

  • Master Philosophy

    A multivariable prediction model for osteoporotic fracture and low bone density in a lung cancer screening cohort

    Associate Advisor

    Other advisors: Professor Kwun Fong, Associate Professor Henry Marshall

Completed supervision

Enquiries

For media enquiries about Professor Ian Yang's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au